These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24231167)

  • 1. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.
    Carroll D; Hallett V; McDougle CJ; Aman MG; McCracken JT; Tierney E; Arnold LE; Sukhodolsky DG; Lecavalier L; Handen BL; Swiezy N; Johnson C; Bearss K; Vitiello B; Scahill L
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):57-72. PubMed ID: 24231167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Adler BA; Wink LK; Early M; Shaffer R; Minshawi N; McDougle CJ; Erickson CA
    Autism; 2015 Jan; 19(1):102-6. PubMed ID: 24571823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
    Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacologic management of serious behavioral disturbance in ASD.
    Stigler KA
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):73-82. PubMed ID: 24231168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing irritability and aggression in autism spectrum disorders in children and adolescents.
    Robb AS
    Dev Disabil Res Rev; 2010; 16(3):258-64. PubMed ID: 20981764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.
    Scahill L; Aman MG; McDougle CJ; Arnold LE; McCracken JT; Handen B; Johnson C; Dziura J; Butter E; Sukhodolsky D; Swiezy N; Mulick J; Stigler K; Bearss K; Ritz L; Wagner A; Vitiello B
    J Autism Dev Disord; 2009 May; 39(5):720-9. PubMed ID: 19096921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability.
    Parikh MS; Kolevzon A; Hollander E
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):157-78. PubMed ID: 18439113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study.
    Troost PW; Althaus M; Lahuis BE; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):561-73. PubMed ID: 17069545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
    Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
    J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials.
    Scahill L; Hallett V; Aman MG; McDougle CJ; Eugene Arnold L; McCracken JT; Tierney E; Deng Y; Dziura J; Vitiello B;
    J Autism Dev Disord; 2013 Mar; 43(3):739-46. PubMed ID: 23104617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.
    Buitelaar JK; van der Gaag RJ; Cohen-Kettenis P; Melman CT
    J Clin Psychiatry; 2001 Apr; 62(4):239-48. PubMed ID: 11379837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone use in autism spectrum disorders: a retrospective review of a clinic-referred patient population.
    Lemmon ME; Gregas M; Jeste SS
    J Child Neurol; 2011 Apr; 26(4):428-32. PubMed ID: 20929907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective review of clozapine in the treatment of patients with autism spectrum disorder and severe disruptive behaviors.
    Beherec L; Lambrey S; Quilici G; Rosier A; Falissard B; Guillin O
    J Clin Psychopharmacol; 2011 Jun; 31(3):341-4. PubMed ID: 21508854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
    Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.